| dysentery, amebic | Dysentery resulting from ulcerative inflammation of the bowel, caused chiefly by infection with entamoeba histolytica. This condition may be associated with amebic infection of the liver and other distant sites. (12 Dec 1998) |
|---|---|
| dysentery, bacillary | An infectious disease caused by bacteria of the genus shigella. This condition is characterised by intestinal pain and diarrhoea. (12 Dec 1998) |
| dyserethism | A condition of slow response to stimuli. Origin: dys-+ G. Erethismos, irritation (05 Mar 2000) |
| dysergia | Lack of harmonious action between the muscles concerned in executing any definite voluntary movement. Origin: dys-+ G. Ergon, work (05 Mar 2000) |
| dysesthesia | An unpleasant abnormal sensation, whether spontaneous or evoked. Origin: Gr. Aisthesis = sensation (16 Dec 1997) |
| dysfibrinogenaemia | An autosomal dominant disorder of qualitatively abnormal fibrinogens of various types; each type is named for the city in which the abnormal fibrinogen was discovered. Examples include: 1) Amsterdam, Bethesda II, Cleveland, Los Angeles, Saint Louis, Zurich I and II: major defect, aggregation of fibrin monomers; thrombin time prolonged; inhibitory effect on normal clotting; asymptomatic; 2) Bethesda I and Detroit: major defect, fibrinopeptide release; thrombin time prolonged; inhibitory effect on normal clotting; abnormal bleeding; 3) Baltimore: major defect, fibrinopeptide release; thrombin time prolonged; no inhibitory effect on normal clotting; bleeding and thrombosis; 4) Leuven: major defect, questionable aggregation of fibrin monomers; thrombin time prolonged; slight inhibitory effect on normal clotting; abnormal bleeding; 5) Metz: major defect unreported; thrombin time infinite; effect on normal clotting unreported; abnormal bleeding; 6) Nancy: major defect, aggregation of fibrin monomers; thrombin time prolonged; slight inhibitory effect on normal clotting; asymptomatic; 7) Oklahoma: major defect unreported; thrombin time normal; no effect on normal clotting; abnormal bleeding; 8) Oslo: major defect unreported; thrombin time shortened; effect on normal clotting unreported; abnormal thrombosis; 9) Parma: major defect unreported; thrombin time infinite; no inhibitory effect on normal clotting; abnormal bleeding; 10) Paris I: major defect unreported; thrombin time infinite; inhibitory effect on normal clotting; asymptomatic; 11) Paris II: major defect unreported; thrombin time prolonged; inhibitory effect on normal clotting; asymptomatic; 12) Troyes: major defect unreported; thrombin time prolonged; effect on normal clotting unreported; asymptomatic; 13) Vancouver: major defect unreported; thrombin time prolonged; no effect on normal clotting; abnormal bleeding; 14) Wiesbaden: major defect, aggregation of fibrin monomers; thrombin time prolonged; inhibitory effect on normal clotting; bleeding and thrombosis. (05 Mar 2000) |
| dysfunction | Disturbance, impairment or abnormality of the functioning of an organ. (18 Nov 1997) |
| dysfunction, erectile | A consistent inability to sustain an erection sufficient for sexual intercourse. Also commonaly known as impotence. Medically, the term erectile dysfunction is used to differentiate impotence from other problems that interfere with sexual intercourse (such as lack of sexual desire and problems with ejaculation and orgasm). Impotence usually has a physical cause, such as disease, injury, drug side-effects, or a disorder that impairs blood flow in the penis. Impotence is treatable in all age groups. (12 Dec 1998) |
| dysfunctional | Working improperly or abnormally. (16 Dec 1997) |
| dysgammaglobulinaemia | An immunologic deficiency state characterised by selective deficiencies of one or more, but not all, classes of immunoglobulins. (12 Dec 1998) |
| dysgenesis | Defective development. (18 Nov 1997) |
| dysgenic | <cell biology> System of breeding or selection that is genetically deleterious or disadvantageous. Origin: Gr. Gennan = to produce (18 Nov 1997) |
| dysgerminoma | <oncology, tumour> A cancerous neoplasm, or abnormal growth, of the ovary which is thought to arise from primordial germ line cells while the individual is still an embryo and the ovary has not yet been sexually differentiated from the generic gonad. (09 Oct 1997) |
| dysgeusia | <symptom> Distortion of the sense of taste. Origin: Gr. Geusis = taste (18 Nov 1997) |
| dysgnathia | Any abnormality that extends beyond the teeth and includes the maxilla or mandible, or both. Origin: dys-+ G. Gnathos, jaw (05 Mar 2000) |